STOCK PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic decline today following the unexpected termination of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by more than fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts spec